Eye Diseases
Showing NaN - NaN of 7
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)
Recruiting
- Retinitis Pigmentosa
- +7 more
- Ultevursen
- Sham-procedure
-
San Diego, California
- +14 more
Jul 29, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Natural History Study of CEP290-Related Retinal Degeneration
Completed
- Blindness
- +7 more
-
Miami, Florida
- +6 more
May 18, 2022
Rate of Progression in EYS Related Retinal Degeneration
Active, not recruiting
- Retinitis Pigmentosa
- Eye Diseases
-
San Francisco, California
- +19 more
Feb 3, 2022
Eye Diseases Trial in Worldwide (Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Suspension Depot, 30 mg/mL,
Completed
- Eye Diseases
- Anecortave Acetate Sterile Suspension, 6 mg/mL
- +3 more
-
Jacksonville, Florida
- +11 more
Nov 27, 2012